Charles River Laboratories International, Inc.
CRL
$175.92
$6.653.93%
| 12/28/2024 | 09/28/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.71% | -1.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.71% | -1.59% | |||
| Cost of Revenue | 7.29% | -2.49% | |||
| Gross Profit | -14.68% | 0.01% | |||
| SG&A Expenses | 3.97% | 13.23% | |||
| Depreciation & Amortization | 27.22% | 0.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.32% | 0.65% | |||
| Operating Income | -47.34% | -12.89% | |||
| Income Before Tax | -337.60% | -23.75% | |||
| Income Tax Expenses | -114.53% | -17.51% | |||
| Earnings from Continuing Operations | -404.07% | -25.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -17.24% | -254.44% | |||
| Net Income | -407.93% | -25.96% | |||
| EBIT | -47.34% | -12.89% | |||
| EBITDA | -27.78% | -7.74% | |||
| EPS Basic | -415.65% | -23.45% | |||
| Normalized Basic EPS | -72.25% | -11.94% | |||
| EPS Diluted | -417.14% | -23.56% | |||
| Normalized Diluted EPS | -72.15% | -11.76% | |||
| Average Basic Shares Outstanding | -0.50% | -0.30% | |||
| Average Diluted Shares Outstanding | -0.86% | -0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
